# Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not

> **NCT05871099** · PHASE3 · RECRUITING · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 616 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **PROCEDURE:** Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

## Key facts

- **NCT ID:** NCT05871099
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-20
- **Primary completion:** 2030-12
- **Final completion:** 2030-12
- **Target enrollment:** 616 (ESTIMATED)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05871099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05871099, "Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05871099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*